_id ManufacturerName OrganizationType Country VaccineName VaccineSubName TradeName ProductionTechnology VaccineType CreateDate 1 Abbott Biologicals Public Organization Netherlands Influenza Seasonal Influenza; Quadrivalent Influvac Primary culture technology "" 2023-05-25T10:33:39 2 Abbott Biologicals Public Organization Netherlands Influenza Seasonal Influenza; Quadrivalent Influvac Tetra Primary culture technology "" 2023-05-25T10:33:39 3 Abbott Biologicals Public Organization Netherlands Influenza Seasonal Influenza; Trivalent Serinflu Primary culture technology "" 2023-05-25T10:33:39 4 Adimmune Public Organization Taiwan "" "" "" "" "" 2023-05-25T10:33:39 5 AJ Vaccine (Staten Serum Institute) Public Organization Denmark IPV IPV IPV Vaccine SSI Mammalian cell culture technology "" 2023-05-25T10:33:39 6 AJ Vaccine (Staten Serum Institute) Public Organization Denmark IPV IPV PICOVAX Mammalian cell culture technology "" 2023-05-25T10:33:39 7 AMSON Public Organization Pakistan "" "" "" "" "" 2023-05-25T10:33:39 8 AnGes Public Organization Japan "" "" "" "" "" 2023-05-25T10:33:39 9 Anhui Zhifei Longcom Biopharmaceutical "" China Covid-19 Covid-19 Zifivax Mammalian cell culture technology "" 2023-05-25T10:33:39 10 Arabio Public Organization Saudi Arabia "" "" "" "" "" 2023-05-25T10:33:39 11 Arcturus Therapeutics "" United States of America "" "" "" "" "" 2023-05-25T10:33:39 12 AstraZeneca Public Organization United Kingdom of Great Britain and Northern Ireland Covid-19 Covid-19 Vaxzevria Mammalian cell culture technology "" 2023-05-25T10:33:39 13 Bavarian Nordic Public Organization Denmark "" "" "" "" "" 2023-05-25T10:33:39 14 Baxter Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 15 Beijing Bio-Institute of Biological Products Public Organization China IPV Sabin IPV Sabin strain polio inactivated vaccine (Vero cells) Mammalian cell culture technology "" 2023-05-25T10:33:39 16 Beijing Bio-Institute of Biological Products Public Organization China MMR MMR Measles, Mumps and Rubella Combined Vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 17 Beijing Minhai Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 18 Beijing Zhifei Luzhu Biopharmaceutical "" China "" "" "" "" "" 2023-05-25T10:33:39 19 Berna Biotech Public Organization South Korea Influenza Seasonal Influenza; Trivalent inflexal V Primary culture technology "" 2023-05-25T10:33:39 20 Bharat Biotech Public Organization India Covid-19 Covid-19 Covaxin Mammalian cell culture technology "" 2023-05-25T10:33:39 21 Bharat Biotech Public Organization India Rota Rota Rotavac Mammalian cell culture technology "" 2023-05-25T10:33:39 22 Bharat Biotech Public Organization India Rota Rota Rotavac 5D Mammalian cell culture technology "" 2023-05-25T10:33:39 23 Biken Public Organization Japan "" "" "" "" "" 2023-05-25T10:33:39 24 Bilthoven Biologicals Public Organization Netherlands IPV IPV Poliomyelitis vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 25 Binnopharm Public Organization Russian Federation "" "" "" "" "" 2023-05-25T10:33:39 26 Biokangtai Public Organization China Covid-19 Covid-19 Inactivated SARS-CoV-2 vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 27 Biological E. Limited Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 28 Bio-Manguinhos/Fiocruz Public Organization Brazil IPV IPV VACINA Mammalian cell culture technology "" 2023-05-25T10:33:39 29 Bio-Manguinhos/Fiocruz Public Organization Brazil MMR MMR Measles, mumps and rubella (MMR) Mammalian cell culture technology "" 2023-05-25T10:33:39 30 Bio-Manguinhos/Fiocruz Public Organization Brazil Rota Rota Human Rotavirus Mammalian cell culture technology "" 2023-05-25T10:33:39 31 Bio-Med Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 32 Biomed Lublin Public Organization Poland "" "" "" "" "" 2023-05-25T10:33:39 33 Bionet-Asia Public Organization Thailand "" "" "" "" "" 2023-05-25T10:33:39 34 BioNTech Public Organization Germany "" "" "" "" "" 2023-05-25T10:33:39 35 BioVac Public Organization South Africa "" "" "" "" "" 2023-05-25T10:33:39 36 BIRMEX Public Organization Mexico Influenza Seasonal Influenza; Trivalent Influenza vaccine Primary culture technology "" 2023-05-25T10:33:39 37 Boryung Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent Boryung flu V quadrivalent vaccine inj. Primary culture technology "" 2023-05-25T10:33:39 38 Boryung Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent Boryung flu VIII tetra vaccine inj. Primary culture technology "" 2023-05-25T10:33:39 39 Boryung Public Organization South Korea Influenza Seasonal Influenza; Trivalent Boryung flu vaccine V inj. Primary culture technology "" 2023-05-25T10:33:39 40 Boryung Public Organization South Korea Influenza Seasonal Influenza; Trivalent Boryung flu vaccine VIII-TF inj. Primary culture technology "" 2023-05-25T10:33:39 41 Boryung Public Organization South Korea IPV IPV IPVAX Mammalian cell culture technology "" 2023-05-25T10:33:39 42 BravoVax Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 43 Bul Bio - National Center of Infectious and Parasitic Diseases (BB-NCIPD) Public Organization Bulgaria "" "" "" "" "" 2023-05-25T10:33:39 44 Butantan Public Organization Brazil HPV HPV4 Vacina papilomavirus humano tipo, 6, 11, 16 e 18 (recombinante) Microbial-based production platform "" 2023-05-25T10:33:39 45 Butantan Public Organization Brazil Influenza Seasonal Influenza; Trivalent Seasonal Influenza Vaccine Primary culture technology "" 2023-05-25T10:33:39 46 CanSino Biologics Public Organization China Covid-19 Covid-19 Convidecia Mammalian cell culture technology "" 2023-05-25T10:33:39 47 Center for Genetics Engineering and Biotechnology (CIGB) "" Cuba Covid-19 Covid-19 Abdala Mammalian cell culture technology "" 2023-05-25T10:33:39 48 Centro de Ingenieria Genetica y Biotecnologia (CIGB) Public Organization Cuba "" "" "" "" "" 2023-05-25T10:33:39 49 Changchun BCHT Biotechnology Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 50 Changchun Changsheng Public Organization China Influenza Seasonal Influenza; Quadrivalent Influenza quadrivalent Primary culture technology "" 2023-05-25T10:33:39 51 Chengdu Institute of Biological Products Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 52 Chengdu Kanghua Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 53 China National Biotech Group Keygen University China "" "" "" "" "" 2023-05-25T10:33:39 54 China National Biotech Group Lanzhou University China Rota Rota LLR Mammalian cell culture technology "" 2023-05-25T10:33:39 55 China National Biotech Group Shanghai University China MMR MMR Measles, Mumps and Rubella Combined Vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 56 China National Biotech Group Tiantan University China "" "" "" "" "" 2023-05-25T10:33:39 57 China National Biotech Group Wuhan University China "" "" "" "" "" 2023-05-25T10:33:39 58 Chinese Institute of Medical Biology "" China "" "" "" "" "" 2023-05-25T10:33:39 59 Chiron Behring Vaccines Private Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 60 Chumakov Federal Scientific Center "" Russian Federation Covid-19 Covid-19 CoviVac Mammalian cell culture technology "" 2023-05-25T10:33:39 61 Clover Biopharmaceuticals "" "" "" "" "" "" "" 2023-05-25T10:33:39 62 Commonwealth Serum Laboratories (CSL) "" Australia "" "" "" "" "" 2023-05-25T10:33:39 63 CPL Biologicals Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 64 CSL "" "" "" "" "" "" "" 2023-05-25T10:33:39 65 CureVac Public Organization Germany "" "" "" "" "" 2023-05-25T10:33:39 66 Dalian Hissen "" China "" "" "" "" "" 2023-05-25T10:33:39 67 DAVAC "" Viet Nam "" "" "" "" "" 2023-05-25T10:33:39 68 Dynavax Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 69 Emergent BioSolutions Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 70 Espromed Bio Public Organization Venezuela (Bolivarian Republic of) "" "" "" "" "" 2023-05-25T10:33:39 71 EuBiologics Public Organization South Korea "" "" "" "" "" 2023-05-25T10:33:39 72 Ezequiel Dias Foundation (FUNED) Government Brazil "" "" "" "" "" 2023-05-25T10:33:39 73 Farmeks Public Organization Ukraine "" "" "" "" "" 2023-05-25T10:33:39 74 Finlay Institute of Vaccines "" Cuba Covid-19 Covid-19 Soberana 2 Mammalian cell culture technology "" 2023-05-25T10:33:39 75 Fosun Pharma "" China "" "" "" "" "" 2023-05-25T10:33:39 76 Fundacao Ataulpho de Paiva (FAP) "" Brazil "" "" "" "" "" 2023-05-25T10:33:39 77 Gamaleya Government Russian Federation Covid-19 Covid-19 Sputnik Light Mammalian cell culture technology "" 2023-05-25T10:33:39 78 Gamaleya Government Russian Federation Covid-19 Covid-19 Sputnik V Mammalian cell culture technology "" 2023-05-25T10:33:39 79 GeneOne Life Science Public Organization South Korea "" "" "" "" "" 2023-05-25T10:33:39 80 Gennova Biopharmaceuticals Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 81 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Infanrix Hexa Fermentation technology "" 2023-05-25T10:33:39 82 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Infanrix Hexa Mammalian cell culture technology "" 2023-05-25T10:33:39 83 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland HPV HPV2 Cervarix Baculovirus-insect cell culture technology "" 2023-05-25T10:33:39 84 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Quadrivalent Fluarix Quadrivalent; Fluarix Tetra; Influsplit Tetra (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 85 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Fluarix (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 86 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland IPV IPV POLIORIX Mammalian cell culture technology "" 2023-05-25T10:33:39 87 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland MMR MMR Priorix Mammalian cell culture technology "" 2023-05-25T10:33:39 88 GlaxoSmithKline Biologicals SA Public Organization United Kingdom of Great Britain and Northern Ireland Rota Rota Rotarix Mammalian cell culture technology "" 2023-05-25T10:33:39 89 GPO-MBP Public Organization Thailand Influenza Seasonal Influenza; Trivalent Trivalent inactivated influenza vaccine Primary culture technology "" 2023-05-25T10:33:39 90 Green Cross Corporation Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent GCFLU Quadrivalent inj. Primary culture technology "" 2023-05-25T10:33:39 91 Green Cross Corporation Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent GCFLU Quadrivalent Multi inj. Primary culture technology "" 2023-05-25T10:33:39 92 Green Cross Corporation Public Organization South Korea Influenza Seasonal Influenza; Trivalent GC FLU inj Primary culture technology "" 2023-05-25T10:33:39 93 Green Cross Corporation Public Organization South Korea Influenza Seasonal Influenza; Trivalent GC FLU Multi inj. Primary culture technology "" 2023-05-25T10:33:39 94 GreenSignal Bio Pharma Limited Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 95 Group 42 (G42) "" "" "" "" "" "" "" 2023-05-25T10:33:39 96 Haffkine Bio Pharmaceutical Government India "" "" "" "" "" 2023-05-25T10:33:39 97 HLL Biotech Limited "" India "" "" "" "" "" 2023-05-25T10:33:39 98 Hualan Biological Bacterin Public Organization China Influenza Seasonal Influenza; Trivalent Influenza Vaccine (Split virion, inactivated) Primary culture technology "" 2023-05-25T10:33:39 99 IBSS Biomed Public Organization Poland "" "" "" "" "" 2023-05-25T10:33:39 100 ID Biomedical Corporation of Quebec "" Canada Influenza Seasonal Influenza; Quadrivalent FluLaval Quadrivalent; Flulaval Tetra (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 101 ID Biomedical Corporation of Quebec "" Canada Influenza Seasonal Influenza; Trivalent Flulaval (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 102 Il-Yand Pharmaceutical Public Organization South Korea Influenza Seasonal Influenza; Trivalent IL-YANG FLU Vaccine INJ. Primary culture technology "" 2023-05-25T10:33:39 103 IMBCAMS Government China Covid-19 Covid-19 SAR-CoV-2 vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 104 IMBCAMS Government China IPV Sabin IPV Inactivated Poliomyelitis Vaccine made from Sabin strains (Vero cells) Mammalian cell culture technology "" 2023-05-25T10:33:39 105 Imunoloski zavod Zagreb Government Croatia "" "" "" "" "" 2023-05-25T10:33:39 106 Incepta Pharmaceuticals Public Organization Bangladesh "" "" "" "" "" 2023-05-25T10:33:39 107 Indian Immunologicals Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 108 Inovio Pharmaceuticals Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 109 Institut Pasteur de Dakar Public Enterprise France "" "" "" "" "" 2023-05-25T10:33:39 110 Institut Pasteur de Tunis Public Enterprise Tunisia "" "" "" "" "" 2023-05-25T10:33:39 111 Institut Pasteur Iran Public Enterprise Iran "" "" "" "" "" 2023-05-25T10:33:39 112 Instituto Biológico Argentino S.A.I.C. (BIOL) Public Organization Argentina "" "" "" "" "" 2023-05-25T10:33:39 113 Intervax Public Organization Canada "" "" "" "" "" 2023-05-25T10:33:39 114 IVAC Government Viet Nam "" "" "" "" "" 2023-05-25T10:33:39 115 Janssen Pharmaceuticals Public Organization Belgium Covid-19 Covid-19 Ad26.COV2.S Mammalian cell culture technology "" 2023-05-25T10:33:39 116 Japan BCG Laboratory Public Organization Japan "" "" "" "" "" 2023-05-25T10:33:39 117 Korea Vaccine Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent Kovax-flu; Kovax-Influ Primary culture technology "" 2023-05-25T10:33:39 118 Korea Vaccine Public Organization South Korea IPV IPV KOVAX POLIO PF Inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 119 LG Chem Public Organization South Korea Influenza Seasonal Influenza; Trivalent Fluplus Tf Inj. Primary culture technology "" 2023-05-25T10:33:39 120 LG Chem Public Organization South Korea IPV Sabin IPV Eupolio Inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 121 Liaoning Chengda Biotechnology (CDBIO) Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 122 M. Aikimbayev Kazakh Scientific Center of Quarantine and Zoonotic Diseases (KSCQZD) Government Kazakhstan "" "" "" "" "" 2023-05-25T10:33:39 123 MassBiologics Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 124 Medicago Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 125 Medigen Vaccine Biologics Government Taiwan Covid-19 Covid-19 MVC-COV1901 "" "" 2023-05-25T10:33:39 126 MedImmune "" United States of America Influenza Seasonal Influenza; Quadrivalent FluMist Quadrivalent; Fluenz Tetra (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 127 MedImmune "" United States of America Influenza Seasonal Influenza; Trivalent FluMist; Fluenz (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 128 Merck Sharp & Dohme (MSD) Public Organization United States of America DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Vaxelis Fermentation technology "" 2023-05-25T10:33:39 129 Merck Sharp & Dohme (MSD) Public Organization United States of America DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Vaxelis Mammalian cell culture technology "" 2023-05-25T10:33:39 130 Merck Sharp & Dohme (MSD) Public Organization United States of America HPV HPV4 Gardasil Microbial-based production platform "" 2023-05-25T10:33:39 131 Merck Sharp & Dohme (MSD) Public Organization United States of America HPV HPV9 Gardasil 9 Microbial-based production platform "" 2023-05-25T10:33:39 132 Merck Sharp & Dohme (MSD) Public Organization United States of America MMR MMR rHA M-M-R II Mammalian cell culture technology "" 2023-05-25T10:33:39 133 Merck Sharp & Dohme (MSD) Public Organization United States of America Rota Rota Rotateq Mammalian cell culture technology "" 2023-05-25T10:33:39 134 Microgen Government Russian Federation Influenza Seasonal Influenza; Trivalent Grippol Primary culture technology "" 2023-05-25T10:33:39 135 Microgen Government Russian Federation Influenza Seasonal Influenza; Trivalent Sovigripp Primary culture technology "" 2023-05-25T10:33:39 136 Ministry of Defense, Russia Government Russian Federation "" "" "" "" "" 2023-05-25T10:33:39 137 Moderna Public Organization United States of America Covid-19 Covid-19 Spikevax "" "" 2023-05-25T10:33:39 138 NANOLEK Public Organization Russian Federation IPV IPV Polymilex Mammalian cell culture technology "" 2023-05-25T10:33:39 139 North China Pharmaceutical Group Corp. (NCPC) "" China "" "" "" "" "" 2023-05-25T10:33:39 140 Novartis Public Organization Switzerland Influenza Seasonal Influenza; Trivalent Begrivac Primary culture technology "" 2023-05-25T10:33:39 141 Novavax Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 142 Nuron Biotech Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 143 Panacea Biotec Public Organization India DTwP-HepB-Hib-IPV DTwP-HepB-Hib-IPV EasySix Fermentation technology "" 2023-05-25T10:33:39 144 Panacea Biotec Public Organization India DTwP-HepB-Hib-IPV DTwP-HepB-Hib-IPV EasySix Mammalian cell culture technology "" 2023-05-25T10:33:39 145 Panacea Biotec Public Organization India IPV IPV POLPROTEC Mammalian cell culture technology "" 2023-05-25T10:33:39 146 Pasteur Institute of India Government India "" "" "" "" "" 2023-05-25T10:33:39 147 PaxVax Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 148 Petrovax Public Organization Russian Federation Influenza Seasonal Influenza; Quadrivalent Grippol Quadrivalent Primary culture technology "" 2023-05-25T10:33:39 149 Petrovax Public Organization Russian Federation Influenza Seasonal Influenza; Trivalent Grippol Neo Primary culture technology "" 2023-05-25T10:33:39 150 Petrovax Public Organization Russian Federation Influenza Seasonal Influenza; Trivalent Grippol Plus Primary culture technology "" 2023-05-25T10:33:39 151 Pfizer Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 152 Pfizer/BioNTech "" Germany Covid-19 Covid-19 Comirnaty "" "" 2023-05-25T10:33:39 153 POLYVAC Government Viet Nam Rota Rota Rotavin-M1 Mammalian cell culture technology "" 2023-05-25T10:33:39 154 Protein Sciences Corporation "" United States of America Influenza Seasonal Influenza; Trivalent Flublok (Northern hemisphere) Baculovirus-insect cell culture technology "" 2023-05-25T10:33:39 155 Providence Therapeutics "" Canada "" "" "" "" "" 2023-05-25T10:33:39 156 PT Bio Farma (Persero) University Indonesia IPV IPV Inactivated polio vaccine (IPV, Bulk from Sanofi Pasteur SA) Mammalian cell culture technology "" 2023-05-25T10:33:39 157 Razi Institute Public Organization Iran MMR MMR MMR Mammalian cell culture technology "" 2023-05-25T10:33:39 158 Research Institute for Biological Safety Problems "" Kazakhstan Covid-19 Covid-19 QazCovid-in Mammalian cell culture technology "" 2023-05-25T10:33:39 159 Saint-Petersburg Scientific Research Institute of vaccines and sera (SPbSRIVS) Government Russian Federation "" "" "" "" "" 2023-05-25T10:33:39 160 Sanofi Pasteur Public Organization France Dengue Dengue Dengvaxia "" "" 2023-05-25T10:33:39 161 Sanofi Pasteur Public Organization France Dengue Dengue DENGVAXIA TEST other "" 2023-05-25T10:33:39 162 Sanofi Pasteur Public Organization France DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Hexavac, Hexaxim, Hexyon Fermentation technology "" 2023-05-25T10:33:39 163 Sanofi Pasteur Public Organization France DTaP-HepB-Hib-IPV DTaP-HepB-Hib-IPV Hexavac, Hexaxim, Hexyon Mammalian cell culture technology "" 2023-05-25T10:33:39 164 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent Flublok Quadrivalent (Northern hemisphere) Baculovirus-insect cell culture technology "" 2023-05-25T10:33:39 165 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent Fluzone High-Dose Quadrivalent (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 166 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent Fluzone Intradermal Quadrivalent Primary culture technology "" 2023-05-25T10:33:39 167 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent Fluzone Quadrivalent (Southern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 168 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent Fluzone Quadrivalent; FluQuadri (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 169 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Quadrivalent VaxigripTetra Primary culture technology "" 2023-05-25T10:33:39 170 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Trivalent Fluzone (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 171 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Trivalent Fluzone (Southern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 172 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Trivalent Fluzone High-Dose Trivalent (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 173 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Trivalent Fluzone Intradermal Trivalent Primary culture technology "" 2023-05-25T10:33:39 174 Sanofi Pasteur Public Organization France Influenza Seasonal Influenza; Trivalent Vaxigrip Primary culture technology "" 2023-05-25T10:33:39 175 Sanofi Pasteur Public Organization France IPV IPV IMOVAX POLIO Mammalian cell culture technology "" 2023-05-25T10:33:39 176 Sanofi Pasteur/GSK "" France "" "" "" "" "" 2023-05-25T10:33:39 177 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Quadrivalent Afluria Quadrivalent (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 178 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Quadrivalent Afluria Quadrivalent (Southern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 179 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Quadrivalent Fluad Quadrivalent (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 180 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Quadrivalent Flucelvax Quadrivalent Mammalian cell culture technology "" 2023-05-25T10:33:39 181 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Afluria (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 182 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Afluria (Southern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 183 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Agriflu Primary culture technology "" 2023-05-25T10:33:39 184 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Agrippal; Agrippal S1; Chiroflu; Begripal; Sandovac Primary culture technology "" 2023-05-25T10:33:39 185 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Fluad (Northern hemisphere) Primary culture technology "" 2023-05-25T10:33:39 186 Seqirus Limited Public Organization United Kingdom of Great Britain and Northern Ireland Influenza Seasonal Influenza; Trivalent Fluvirin Primary culture technology "" 2023-05-25T10:33:39 187 Serum Institute of India Public Organization India Covid-19 Covid-19 Covishield Mammalian cell culture technology "" 2023-05-25T10:33:39 188 Serum Institute of India Public Organization India Influenza Seasonal Influenza; Trivalent Nasovac-S Influenza Vaccine, Live, Attenuated (Human) Primary culture technology "" 2023-05-25T10:33:39 189 Serum Institute of India Public Organization India IPV IPV POLIOVAC Mammalian cell culture technology "" 2023-05-25T10:33:39 190 Serum Institute of India Public Organization India IPV IPV POLIOVAC PFS Mammalian cell culture technology "" 2023-05-25T10:33:39 191 Serum Institute of India Public Organization India MMR MMR Measles,Mumps and Rubella Vaccine Live attenuated Mammalian cell culture technology "" 2023-05-25T10:33:39 192 Serum Institute of India Public Organization India Rota Rota Rotasiil Mammalian cell culture technology "" 2023-05-25T10:33:39 193 Serum Institute of India Public Organization India Rota Rota Rotasiil Thermo Mammalian cell culture technology "" 2023-05-25T10:33:39 194 Serum Institute of India Public Organization India Rota Rota Rotasiil-liquid Mammalian cell culture technology "" 2023-05-25T10:33:39 195 Sevapharma A.S Public Organization Czechia MMR MMR TRIVIVAC Mammalian cell culture technology "" 2023-05-25T10:33:39 196 Shanghai Institute of Biological Products "" China Influenza Seasonal Influenza; Trivalent Influenza virus split vaccine Primary culture technology "" 2023-05-25T10:33:39 197 Shantha Biotechnics Public Organization India IPV IPV ShanIPV Mammalian cell culture technology "" 2023-05-25T10:33:39 198 Shifa Pharmed "" Iran Covid-19 Covid-19 CovIran Barekat "" "" 2023-05-25T10:33:39 199 Siam Bioscience Public Organization Thailand Covid-19 Covid-19 COVID-19 Vaccine (ChAdOx1-S [recombinant]) Mammalian cell culture technology "" 2023-05-25T10:33:39 200 Sinergium Biotech Public Organization Argentina HPV HPV4 Silgard VPH Microbial-based production platform "" 2023-05-25T10:33:39 201 Sinergium Biotech Public Organization Argentina Influenza Seasonal Influenza; Trivalent Fluxvir Primary culture technology "" 2023-05-25T10:33:39 202 Sinergium Biotech Public Organization Argentina Influenza Seasonal Influenza; Trivalent Viraflu Primary culture technology "" 2023-05-25T10:33:39 203 Sinopharm University China MMR MMR Measles, Mumps and Rubella Combined Vaccine Mammalian cell culture technology "" 2023-05-25T10:33:39 204 Sinovac Biotech Public Organization China Covid-19 Covid-19 CoronaVac Mammalian cell culture technology "" 2023-05-25T10:33:39 205 SK Bioscience Public Organization South Korea Covid-19 Covid-19 COVID-19 Vaccine (ChAdOx1-S [recombinant]) Mammalian cell culture technology "" 2023-05-25T10:33:39 206 SK Bioscience Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent SKYCellflu Quadrivalent inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 207 SK Bioscience Public Organization South Korea Influenza Seasonal Influenza; Quadrivalent SKYCellflu Quadrivalent Multi inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 208 SK Bioscience Public Organization South Korea Influenza Seasonal Influenza; Trivalent SKYCellflu inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 209 SK Bioscience Public Organization South Korea Influenza Seasonal Influenza; Trivalent SKYCellflu Multi inj. Mammalian cell culture technology "" 2023-05-25T10:33:39 210 State Research Center of Virology and Biotechnology (VECTOR) Government Russian Federation Covid-19 Covid-19 EpiVacCorona Nucleic acid-based technology "" 2023-05-25T10:33:39 211 Staten Serum Institute "" Denmark "" "" "" "" "" 2023-05-25T10:33:39 212 Takeda Pharmaceutical "" Japan "" "" "" "" "" 2023-05-25T10:33:39 213 Thai Red Cross Government Thailand "" "" "" "" "" 2023-05-25T10:33:39 214 The Government Pharmaceutical Organization (GPO) Government Thailand "" "" "" "" "" 2023-05-25T10:33:39 215 Torlak Government Serbia "" "" "" "" "" 2023-05-25T10:33:39 216 VABIOTECH University Viet Nam "" "" "" "" "" 2023-05-25T10:33:39 217 Vacsera Public Organization Egypt "" "" "" "" "" 2023-05-25T10:33:39 218 Valneva Public Organization France "" "" "" "" "" 2023-05-25T10:33:39 219 Vaxart Public Organization United States of America "" "" "" "" "" 2023-05-25T10:33:39 220 Vaxine Public Organization Australia "" "" "" "" "" 2023-05-25T10:33:39 221 Vaxxinity "" "" "" "" "" "" "" 2023-05-25T10:33:39 222 Vector-BiAlgam "" "" "" "" "" "" "" 2023-05-25T10:33:39 223 VINS Bioproducts Public Organization India "" "" "" "" "" 2023-05-25T10:33:39 224 Walvax Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 225 Xiamen Innovax Biotech Public Organization China HPV HPV2 Cecolin Microbial-based production platform "" 2023-05-25T10:33:39 226 Zhejiang Pukang Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 227 Zhifei Biological Products Public Organization China "" "" "" "" "" 2023-05-25T10:33:39 228 Zydus Cadila Public Organization India Covid-19 Covid-19 ZyCoV-D "" "" 2023-05-25T10:33:39